3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advan

Details 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advan 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advan

1996-06-27

1997-11-18

Feisee, Lila

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

568305, 5303871, 5303891, G01N 3353, C07C20500, C07K 1600

Patent

active

056886535

ABSTRACT:
The present invention relates to advanced glycosylation endproducts (AGEs), and particularly to novel cyclopentenone aminoreductones, 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-ones. Such AGEs can be used in various diagnostic and therapeutic methods.

Affiliated with

Also associated with

Rating

3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advan does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advan will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1564685